Larvol Delta - Atossa-Therapeutics-Presents-Data-from-40mg-Cohort-of-Phase-2-EVANGELINE-Clinical-Trial-Showing-100-Disease-Control-Rate-After-24Weeks-of-Treatment-with-ZEndoxifen

Z-endoxifen - Atossa Therap

https://www.globenewswire.com/news-release/2024/04/09/2860236/0/en/Atossa-Therapeutics-Presents-Data-from-40mg-Cohort-of-Phase-2-EVANGELINE-Clinical-Trial-Showing-100-Disease-Control-Rate-After-24-Weeks-of-Treatment-with-Z-Endoxifen.html

Apr 9, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next